News
Nadav Ahituv, PhD
Tue Feb 4, 2025
Department of Bioengineering and Therapeutic Sciences professor Nadav Ahituv is part of a team of researchers using the gene editing technology CRISPR to deprive tumors of nutrition.
Mon Nov 27, 2017
Burchard Lab colleagues step up to help residents of the island get fresh water.
Tue Nov 21, 2017
A tiny implant promises to simplify how glaucoma drugs are administered, making life easier for aging patients.
Thu Oct 19, 2017
A UC San Francisco-created, insulin-generating implant that utilizes nanotechnology is closer to becoming a real treatment for diabetes, after being acquired by a San Francisco-based startup.
The biotechnology company Encellin acquired exclusive worldwide rights to the technology, originally developed in the laboratory of Tejal Desai,...
Mon Oct 16, 2017
The Department of Bioengineering and Therapeutic Sciences (BTS) is celebrating Hubert Sylvester on the occasion of his 35th employment anniversary at UCSF.
Before joining the staff at UCSF, Sylvester was attending college. Over the course of his UCSF career, he has served as a clerk, an assistant store keeper, a member...
Fri Oct 6, 2017
Kidney failure is a debilitating and ultimately deadly illness, and a health policy crisis. With 468,000 people on dialysis in the U.S., costing the government $31 billion dollars a year, very little money is spent on researching alternatives to current treatments.
Wired magazine’s Megan Molteni visited Shuvo Roy, PhD, to check in on...
Wed Sep 20, 2017
Strategic plan progress report. Research: Driving the development of innovative and precise drugs, medical devices, and diagnostic tests. Flu treatments; Tackling antimalarial resistance; Attacking hard targets; Plotting cell maps; Safer opioid pain killer; Cellular construction; New products through bioengineering; Regulatory science leadership;...
Thu Sep 14, 2017
“There are lots of important problems. Only attack those for which you can divine simple experiments with clear answers.”—Julius Axelrod
This quotation is a guiding principle for Su Guo, PhD, professor in the Department of Bioengineering and Therapeutic Sciences (BTS). Her research employs the unique strengths of a simple vertebrate,...
Tue Sep 5, 2017
Kathy Giacomini, PhD, a leader in the field of pharmacogenomics, has been named the 2017 recipient of the North American Scientific Achievement Award, presented by the International Society for the Study of Xenobiotics (ISSX). ISSX is an international association of scientists that promotes the understanding of the interactions of medicines and...
Thu Aug 31, 2017
The common lab practice of adding antibiotics to cell cultures to prevent contamination can actually induce genetic changes in the cells, a paper senior-authored by Nadav Ahituv, PhD, found. Ahituv is a faculty member in the Department of Bioengineering and Therapeutic Sciences, a joint department of the UCSF Schools of Pharmacy and Medicine....